Literature DB >> 7747773

Tumors in Rubinstein-Taybi syndrome.

R W Miller1, J H Rubinstein.   

Abstract

The 14 tumors reported in Rubinstein-Taybi syndrome since 1989, when added to the 22 previously reported, are beginning to show a pattern of neural and developmental tumors, especially of the head, which is malformed in the syndrome. Among the neoplasms were 12 of the nervous system: 2 each of oligodendroglioma, medulloblastoma, neuroblastoma, and benign meningioma, a pheochromocytoma, and 3 other benign tumors; 2 of nasopharyngeal rhabdomyosarcoma; and 1 each of leiomyosarcoma, seminoma, and embryonal carcinoma. Among the other benign tumors were an odontoma, a choristoma, a dermoid cyst, and 2 pilomatrixomas.

Entities:  

Mesh:

Year:  1995        PMID: 7747773     DOI: 10.1002/ajmg.1320560125

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  68 in total

1.  Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.

Authors:  Wei Hong; Alexander Y Kim; Sokun Ky; Carrie Rakowski; Sang-Beom Seo; Debabrata Chakravarti; Michael Atchison; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

Review 2.  The sonic hedgehog-patched-gli pathway in human development and disease.

Authors:  E H Villavicencio; D O Walterhouse; P M Iannaccone
Journal:  Am J Hum Genet       Date:  2000-09-21       Impact factor: 11.025

3.  Functional interaction between the coactivator Drosophila CREB-binding protein and ASH1, a member of the trithorax group of chromatin modifiers.

Authors:  F Bantignies; R H Goodman; S M Smolik
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 4.  Insight into the tumor suppressor function of CBP through the viral oncoprotein tax.

Authors:  K Van Orden; J K Nyborg
Journal:  Gene Expr       Date:  2000

5.  Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.

Authors:  Wendell S Fortson; Shubhalaxmi Kayarthodi; Yasuo Fujimura; Huali Xu; Roland Matthews; William E Grizzle; Veena N Rao; Ganapathy K Bhat; E Shyam P Reddy
Journal:  Int J Oncol       Date:  2011-04-21       Impact factor: 5.650

6.  Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes.

Authors:  Jihong Chen; Feras M Ghazawi; Qiao Li
Journal:  Epigenetics       Date:  2010-08-16       Impact factor: 4.528

7.  Epigenetic mechanisms of Rubinstein-Taybi syndrome.

Authors:  Elizabeth Park; Yunha Kim; Hyun Ryu; Neil W Kowall; Junghee Lee; Hoon Ryu
Journal:  Neuromolecular Med       Date:  2014-01-01       Impact factor: 3.843

Review 8.  Epigenetic alterations in hematopoietic malignancies.

Authors:  Young Rock Chung; Emma Schatoff; Omar Abdel-Wahab
Journal:  Int J Hematol       Date:  2012-09-27       Impact factor: 2.490

9.  Congenital anomalies and childhood cancer in Great Britain.

Authors:  S A Narod; M M Hawkins; C M Robertson; C A Stiller
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

Review 10.  Epigenetics of neurological cancers.

Authors:  Shaun D Fouse; Joseph F Costello
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.